Abbott Laboratories ABT posted better-than-expected earnings and revenue in the fourth quarter of 2022, although headwinds from its infant formula business and declining sales of COVID-19 testing products are still affecting. to the performance of the company. Abbott posted a profit of $1.0 billion, or 59 cents per share, for the fourth quarter of 2022, down from $1.9 billion, or $1.11 per share, in the same period. quarter 2021. Adjusted earnings per share were $1.03, compared with FactSet consensus of 93 cents. Abbott had $10.1 billion in revenue for the quarter, beating FactSet consensus of $9.6 billion. The company’s nutrition business, including…
